The Boston Examiner: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Boston Examiner.

Press releases published on April 28, 2026

Apr. 28, 2026

OMG Launches RFP to Standardize Space Communications Assets

Indeterminate GlobeNewswire

Apr. 28, 2026

Community Boating Inc. Celebrates 80th Anniversary with First Ever 24-Hour Sail-a-thon

Indeterminate GlobeNewswire

Apr. 28, 2026

Sportradar Group AG Investigated For Securities Fraud; Block & Leviton Encourages Investors Who Have Lost Money to Contact the Firm

Indeterminate GlobeNewswire

Apr. 28, 2026

Erasca, Inc. Investigated For Securities Fraud; Block & Leviton Encourages Investors to Contact the Firm to Possibly Recover Losses

Indeterminate GlobeNewswire

Apr. 28, 2026

Paytronix Releases Rewards Hub; Innovative Revamp of Platform Delivers Greater Agility, Visibility

Indeterminate GlobeNewswire

Apr. 28, 2026

Acquia Recognizes 2026 Engage Award Winners for Digital Excellence

Indeterminate GlobeNewswire

Apr. 28, 2026

Quickbase Introduces Pave, a Full-Stack AI App Builder for the Enterprise

Indeterminate GlobeNewswire

Apr. 28, 2026

Alira Health Joins PFMD Effort to Advance Patient-Centered Evidence Generation

Indeterminate GlobeNewswire

Apr. 28, 2026

Thrive Appoints Matt Kosovsky as Chief Financial Officer

Indeterminate GlobeNewswire

Apr. 28, 2026

AI Disruption in Advanced Materials for Extreme Environments Attracts $262 Million+ in Strategic Investments

Indeterminate GlobeNewswire

Apr. 28, 2026

Acquia Announces Significant Updates to Acquia Source and Launches Acquia AI

Indeterminate GlobeNewswire

Apr. 28, 2026

CAMP4 Therapeutics Preprints Pioneering Study on Regulatory RNA Profiling and Gene Upregulation

Indeterminate GlobeNewswire

Apr. 28, 2026

Solid Biosciences Announces Receipt of European Commission Orphan Drug Designation for SGT-003 for the Treatment of Duchenne Muscular Dystrophy

Indeterminate GlobeNewswire

Apr. 28, 2026

Kestrel Therapeutics Announces First Patient Dosed in the Phase 1 Clinical Trial of KST-6051, a Potential Best-in-Class Pan-KRAS Inhibitor, in Patients with KRAS-driven Malignancies

Indeterminate GlobeNewswire

Apr. 28, 2026

Ahold Delhaize USA Expands Digital Commerce Capabilities with SmartCommerce Click2Cart®

Indeterminate GlobeNewswire

Apr. 28, 2026

VistaShares’ AI Infrastructure ETF (AIS) a Top Performer in Its Morningstar Category, Passes $350 Million in Assets

Indeterminate GlobeNewswire

Apr. 28, 2026

Cynet Launches New Capabilities for CyAI Engine That Improves Itself Over Time

Indeterminate GlobeNewswire

Apr. 28, 2026

Anaqua übernimmt Patrix, um seine Führungsposition im Bereich IP-Management auszubauen

Indeterminate GlobeNewswire

Apr. 28, 2026

Anaqua adquiere Patrix para expandir su liderazgo en gestión de PI

Indeterminate GlobeNewswire

Apr. 28, 2026

Anaqua acquiert Patrix en vue de renforcer son leadership dans la gestion de la propriété intellectuelle

Indeterminate GlobeNewswire